Risk of childhood cancer in infants treated with phototherapy for neonatal jaundice

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F24%3A10483033" target="_blank" >RIV/00064165:_____/24:10483033 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/24:10483033
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=dzPsJcYMLP" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=dzPsJcYMLP</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/s41390-024-03315-z" target="_blank" >10.1038/s41390-024-03315-z</a>

Result language
angličtina
Original language name
Risk of childhood cancer in infants treated with phototherapy for neonatal jaundice
Original language description
Phototherapy of neonatal jaundice was first introduced by Cremer et al. as early as 1958, but further studies that focused on demonstrating its safety and efficacy by Lucey et al. were needed to become widely adopted. Since then, phototherapy has become the gold standard in the treatment of neonatal jaundice in fact, approximately 8 million newborn infants are treated annually with phototherapy.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30100 - Basic medicine

Project
<a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)